Transition Therapeutics Announces Appointment of Vice-President of Clinical Operations

22-Jun-2009 - Canada

Transition Therapeutics Inc. announced that Ms. Laura Agensky has been appointed Vice-President of Clinical Operations. Since joining Transition in 2001, Ms. Agensky has managed the execution of all the Company's clinical trials across a diverse set of disease indications including Alzheimer's disease and diabetes. Prior to Transition, she served in multiple clinical development roles at large pharmaceutical, biotechnology and consulting organizations. As Vice-President, Ms. Agensky will continue to lead Transition's clinical operations group.

Other news from the department people

Most read news

More news from our other portals

Fighting cancer: latest developments and advances